Katharine Knobil
Director/Board Member at MARKER THERAPEUTICS, INC.
Net worth: 645 $ as of 2024-03-30
Profile
Presently, Katharine Knobil occupies the position of Chief Medical Officer of Agilent Technologies, Inc. Dr. Knobil is also on the board of Arena Pharmaceuticals, Inc. and Member of The National Academies of Science. Dr. Knobil previously occupied the position of Chief Medical Officer, Head-Research & Development at Kaleido Biosciences, Inc. and Chief Medical Officer & Senior Vice President at GlaxoSmithKline LLC. Dr. Knobil received an undergraduate degree from Cornell University and a doctorate from The University of Texas Southwestern Medical Center.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-06-05 | 150 ( 0.00% ) | 645 $ | 2024-03-30 | |
2023-06-06 | 0 ( -.--% ) | - $ | 2024-03-30 |
Katharine Knobil active positions
Companies | Position | Start |
---|---|---|
MARKER THERAPEUTICS, INC. | Director/Board Member | 2021-12-07 |
PLIANT THERAPEUTICS, INC. | Director/Board Member | 2022-09-13 |
The National Academies of Science
The National Academies of Science Miscellaneous Commercial ServicesCommercial Services The National Academies of Science operates as a private non-profit organization that provides advice in sciences, engineering and medicine. It conducted through seven major program areas: Behavioral and Social Sciences and Education, Earth and Life Studies, Engineering and Physical Sciences, Health and Medicine, Policy and Global Affairs, Transportation Research Board, and the Gulf Research Program. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Former positions of Katharine Knobil
Companies | Position | End |
---|---|---|
AGILENT TECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 2023-12-31 |
ARENA PHARMACEUTICALS | Director/Board Member | 2022-03-10 |
KALEIDO BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2021-01-28 |
The National Health Council
The National Health Council Miscellaneous Commercial ServicesCommercial Services The National Health Council provides united voice for people with chronic diseases and disabilities and their family caregivers. The company was founded in 1920 and is headquartered in Washington, DC. | Director/Board Member | 2018-11-30 |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Chief Tech/Sci/R&D Officer | 2018-11-30 |
Training of Katharine Knobil
Cornell University | Undergraduate Degree |
The University of Texas Southwestern Medical Center | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
AGILENT TECHNOLOGIES, INC. | Health Technology |
MARKER THERAPEUTICS, INC. | Health Technology |
PLIANT THERAPEUTICS, INC. | Health Technology |
KALEIDO BIOSCIENCES, INC. | Health Technology |
Private companies | 6 |
---|---|
Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Health Technology |
The National Academies of Science
The National Academies of Science Miscellaneous Commercial ServicesCommercial Services The National Academies of Science operates as a private non-profit organization that provides advice in sciences, engineering and medicine. It conducted through seven major program areas: Behavioral and Social Sciences and Education, Earth and Life Studies, Engineering and Physical Sciences, Health and Medicine, Policy and Global Affairs, Transportation Research Board, and the Gulf Research Program. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Commercial Services |
The National Health Council
The National Health Council Miscellaneous Commercial ServicesCommercial Services The National Health Council provides united voice for people with chronic diseases and disabilities and their family caregivers. The company was founded in 1920 and is headquartered in Washington, DC. | Commercial Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Patient-Centered Outcomes Research Institute
Patient-Centered Outcomes Research Institute Miscellaneous Commercial ServicesCommercial Services Patient-Centered Outcomes Research Institute operates as a non-profit organization. It funds research that helps patients and care takers to make better decisions about their healthcare choices. The firm focuses on Comparative Clinical Effectiveness Research (CER), CER methods & infrastructure and related research studies. It funds to various private and public sectors including non-profit research organizations and profit research organizations, universities & colleges, hospitals and healthcare systems, laboratories & manufacturers, units of state, local and federal government. The company is headquartered in Washington, DC. | Commercial Services |
- Stock Market
- Insiders
- Katharine Knobil